X T L Biopharmaceuticals reported $11.6M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 46M 39M Jun/2026
Bioline Rx USD 16M 40M Sep/2025
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
X T L Biopharmaceuticals USD 22M 8M Dec/2024